Edition:
India

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

9.21USD
19 Jan 2018
Change (% chg)

$-0.41 (-4.26%)
Prev Close
$9.62
Open
$9.52
Day's High
$9.52
Day's Low
$9.20
Volume
13,010
Avg. Vol
14,123
52-wk High
$15.34
52-wk Low
$9.00

Chart for

About

Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): $214.98
Shares Outstanding(Mil.): 14.71
Dividend: --
Yield (%): --

Financials

BRIEF-Apple Tree Partners Sells 150,000 Shares Of Aileron Therapeutics Inc's Common Stock On Jan 9

* APPLE TREE PARTNERS II LP REPORTS SALE OF 150,000 SHARES OF AILERON THERAPEUTICS INC'S COMMON STOCK ON JAN 9 AT $9.80 PER SHARE - SEC FILING Source text: (http://bit.ly/2DiFGmF) Further company coverage:

12 Jan 2018

BRIEF-Aileron Therapeutics posts Q3 loss of $0.45 per share

* Aileron therapeutics reports third quarter 2017 financial results

10 Nov 2017

BRIEF-Aileron Therapeutics reports second quarter 2017 financial results

* Aileron Therapeutics reports second quarter 2017 financial results

11 Aug 2017

Earnings vs. Estimates